Hyperfine, Inc. (HYPR) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

15/25

Growth 3 Margin 4 Expansion 4 Platform 1 Financial 3

latest quarter score

Earnings Reports

15
Hyperfine (HYPR) Q2 2026: Model 2 Drives 50% Unit Growth, International and Office Verticals Gain Traction
August 07, 2026
19
Hyperfine (HYPR) Q1 2026: Gross Margin Expands 940bps as Next-Gen Subsystem Drives Adoption
June 17, 2026
21
Hyperfine (HYPR) Q2 2025: Gross Margin Jumps 800bps as Next-Gen SWOOP Drives Commercial Inflection
June 16, 2026
19
Hyperfine (HYPR) Q3 2025: Gross Margin Jumps 450bps as Next-Gen MRI Launches Drive Pipeline Expansion
June 16, 2026
19
HYPR Q4 2025: 128% Revenue Surge Reflects Accelerated Adoption of Next-Gen Portable Brain MRI
March 18, 2026
13
Hyperfine (HYPR) Q1 2025: Revenue Headwinds Offset by Diversified Growth Catalysts and 31% Cash Burn Reduction
May 13, 2025
18
Hyperfine (HYPR) Q4 2024: 17% Revenue Growth Sets Stage for Multi-Site and International Expansion
March 17, 2025

Browse all companies